• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ticagrelor: A promising role in preventing multi-organ failure among patients with sepsis due to resistant gram-positive cocci.

作者信息

Jean Shio-Shin, Hsueh Shun-Chung, Hwang Juey-Jen, Hsueh Po-Ren

机构信息

Department of Emergency, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; Department of Emergency Medicine, Department of Emergency and Critical Care Medicine, Wan Fang Hospital, Taipei Medicine University, Taipei, Taiwan.

Department of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

出版信息

J Microbiol Immunol Infect. 2019 Aug;52(4):513-515. doi: 10.1016/j.jmii.2019.06.004. Epub 2019 Jun 26.

DOI:10.1016/j.jmii.2019.06.004
PMID:31280973
Abstract
摘要

相似文献

1
Ticagrelor: A promising role in preventing multi-organ failure among patients with sepsis due to resistant gram-positive cocci.替格瑞洛：在预防耐甲氧西林革兰氏阳性球菌所致脓毒症患者多器官功能衰竭方面具有潜在作用。
J Microbiol Immunol Infect. 2019 Aug;52(4):513-515. doi: 10.1016/j.jmii.2019.06.004. Epub 2019 Jun 26.
2
Third generation P2Y12 antagonists inhibit platelet aggregation more effectively than clopidogrel in a myocardial infarction registry.第三代 P2Y12 拮抗剂在心肌梗死注册研究中比氯吡格雷更有效地抑制血小板聚集。
Thromb Haemost. 2014 Feb;111(2):266-72. doi: 10.1160/TH13-06-0508. Epub 2013 Oct 31.
3
Platelet Reactivity And Circulating Platelet-Derived Microvesicles Are Differently Affected By P2Y Receptor Antagonists.血小板反应性和循环血小板衍生微泡受到 P2Y 受体拮抗剂的不同影响。
Int J Med Sci. 2019 Jan 1;16(2):264-275. doi: 10.7150/ijms.28580. eCollection 2019.
4
Ticagrelor Increases Platelet-Mediated Staphylococcus aureus Killing, Resulting in Clearance of Bacteremia.替卡格雷增加血小板介导的金黄色葡萄球菌杀伤作用，从而清除菌血症。
J Infect Dis. 2021 Nov 16;224(9):1566-1569. doi: 10.1093/infdis/jiab146.
5
Effect of P2Y inhibitors on thrombus stability and endogenous fibrinolysis.P2Y 抑制剂对血栓稳定性和内源性纤维蛋白溶解的影响。
Thromb Res. 2019 Jan;173:102-108. doi: 10.1016/j.thromres.2018.11.023. Epub 2018 Nov 24.
6
Evaluation of ticagrelor pharmacodynamic interactions with reversibly binding or non-reversibly binding P2Y(12) antagonists in an ex-vivo canine model.在体外犬模型中评价可逆结合或不可逆结合的 P2Y(12)拮抗剂与替格瑞洛的药效学相互作用。
Thromb Res. 2012 Oct;130(4):622-8. doi: 10.1016/j.thromres.2012.07.021. Epub 2012 Aug 19.
7
Development and clinical use of prasugrel and ticagrelor.普拉格雷和替格瑞洛的研发与临床应用。
Curr Pharm Des. 2012;18(33):5240-60. doi: 10.2174/138161212803251989.
8
Ticagrelor versus clopidogrel for recovery of vascular function immediately after successful chronic coronary total occlusion recanalization: A randomized clinical trial.替格瑞洛与氯吡格雷对成功慢性冠状动脉完全闭塞再通后血管功能即刻恢复的比较：一项随机临床试验。
Am Heart J. 2018 Oct;204:205-209. doi: 10.1016/j.ahj.2018.07.013. Epub 2018 Aug 2.
9
Impact of immature platelets on platelet response to ticagrelor and prasugrel in patients with acute coronary syndrome.急性冠脉综合征患者血小板不成熟对替格瑞洛和普拉格雷血小板反应的影响。
Eur Heart J. 2015 Dec 1;36(45):3202-10. doi: 10.1093/eurheartj/ehv326. Epub 2015 Jul 27.
10
DAPT Plus Cilostazol is Better Than Traditional DAPT or Aspirin Plus Ticagrelor as Elective PCI for Intermediate-to-Highly Complex Cases: Prospective, Randomized, PRU-Based Study in Taiwan.DAPT 联合西洛他唑优于传统 DAPT 或阿司匹林联合替格瑞洛作为中高危复杂病例的择期 PCI：基于 PRU 的台湾前瞻性随机研究。
Am J Cardiovasc Drugs. 2019 Feb;19(1):75-86. doi: 10.1007/s40256-018-0302-3.

引用本文的文献

1
Use of ticagrelor and the risks of pneumonia and pneumonia-specific death in patients with non-acute coronary syndrome conditions: a population-based cohort study.替格瑞洛的使用与非急性冠状动脉综合征患者肺炎和肺炎相关死亡风险：一项基于人群的队列研究。
Sci Rep. 2021 Oct 14;11(1):20468. doi: 10.1038/s41598-021-00105-z.
2
Antimicrobial Properties on Non-Antibiotic Drugs in the Era of Increased Bacterial Resistance.细菌耐药性增加时代非抗生素药物的抗菌特性
Antibiotics (Basel). 2020 Mar 2;9(3):107. doi: 10.3390/antibiotics9030107.